Hyperfine (NASDAQ:HYPR) Issues Quarterly Earnings Results, Hits Expectations

Key Points

• Hyperfine (NASDAQ:HYPR) reported a quarterly earnings per share of ($0.12), matching analysts' expectations, but posted a negative return on equity of 74.19%.
• The company's stock increased by 5.8% to $1.27 following the earnings report, with a market capitalization of approximately $98.84 million.
• Analysts have mixed views on Hyperfine, with Wells Fargo lowering its price target from $1.29 to $0.68, while B. Riley maintained a "buy" rating.

Hyperfine (NASDAQ:HYPR - Get Free Report) posted its earnings results on Wednesday. The company reported ($0.12) earnings per share for the quarter, meeting the consensus estimate of ($0.12), Zacks reports. Hyperfine had a negative return on equity of 84.82% and a negative net margin of 364.54%. The company had revenue of $2.70 million for the quarter, compared to analyst estimates of $3.00 million. Hyperfine updated its FY 2025 guidance to EPS.

Hyperfine Trading Down 4.0%

Shares of HYPR traded down $0.06 during midday trading on Monday, reaching $1.34. 223,205 shares of the company were exchanged, compared to its average volume of 1,444,266. Hyperfine has a 1-year low of $0.53 and a 1-year high of $1.90. The stock has a 50-day moving average price of $0.92 and a 200-day moving average price of $0.88. The company has a market cap of $103.90 million, a price-to-earnings ratio of -2.58 and a beta of 1.06.

Wall Street Analyst Weigh In

Several brokerages recently commented on HYPR. Wells Fargo & Company upped their price target on shares of Hyperfine from $0.68 to $0.85 and gave the stock an "equal weight" rating in a research report on Friday. Lake Street Capital increased their target price on Hyperfine from $1.50 to $2.00 and gave the stock a "buy" rating in a research report on Thursday. Finally, B. Riley reissued a "buy" rating on shares of Hyperfine in a research report on Tuesday, June 3rd.

About Hyperfine

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.